Industrial Transformation Training Centres - Grant ID: IC170100022
Funder
Australian Research Council
Funding Amount
$4,420,408.00
Summary
ARC Training Centre for Innovative BioEngineering. The ARC Training Centre for Musculoskeletal Biomedical Technologies will provide the next-generation of skilled graduates to overcome industry-focused challenges in musculoskeletal regeneration. The Centre expects to engineer a set of integrated technologies to personalise implants for the unique biological, physical and lifestyle characteristics of the recipient. Expected outcomes of the Centre include embedded bioelectronic sensors to assess a ....ARC Training Centre for Innovative BioEngineering. The ARC Training Centre for Musculoskeletal Biomedical Technologies will provide the next-generation of skilled graduates to overcome industry-focused challenges in musculoskeletal regeneration. The Centre expects to engineer a set of integrated technologies to personalise implants for the unique biological, physical and lifestyle characteristics of the recipient. Expected outcomes of the Centre include embedded bioelectronic sensors to assess and optimise the healing process. In addition, the Centre will produce data for use in deriving the next-generation of implants, giving rise to improved health outcomes, economic benefits, and a skilled workforce able to advance and perpetuate this important field.Read moreRead less
Controlling the adhesome to regulate cell fate on biomaterials. Mesenchymal stem cell-based tissue engineering practices are hampered worldwide by the lack of appreciation and understanding of the matrix-mediated cues that must be provided during adhesion and spreading to drive cells to definitive tissue end points. This project will address these knowledge deficiencies by combining high throughput array technologies, a set of tailorable self-assembling biomaterials and real-time biosensors to r ....Controlling the adhesome to regulate cell fate on biomaterials. Mesenchymal stem cell-based tissue engineering practices are hampered worldwide by the lack of appreciation and understanding of the matrix-mediated cues that must be provided during adhesion and spreading to drive cells to definitive tissue end points. This project will address these knowledge deficiencies by combining high throughput array technologies, a set of tailorable self-assembling biomaterials and real-time biosensors to rapidly, at high resolution, elucidate how mechanotransductive cues determine the fate choice of mesenchymal stem cells, and furthermore, how to manipulate them with smart biomaterial design to achieve desired outcomes for tissue engineering. Read moreRead less
New techniques to detect fetal heart abnormalities. Australia’s national fetal death rate is 6.7 per one thousand births. In Australia’s Indigenous community it surges to 12.3 deaths per one thousand births. Early diagnosis (and management) of abnormal fetu.ses with cardiac defects will go a long way in reducing these numbers. The proposed technology will help set up easy-to-use systems for fetal cardiac abnormality screening and reduce fetal deaths and congenital heart disease burden in adult l ....New techniques to detect fetal heart abnormalities. Australia’s national fetal death rate is 6.7 per one thousand births. In Australia’s Indigenous community it surges to 12.3 deaths per one thousand births. Early diagnosis (and management) of abnormal fetu.ses with cardiac defects will go a long way in reducing these numbers. The proposed technology will help set up easy-to-use systems for fetal cardiac abnormality screening and reduce fetal deaths and congenital heart disease burden in adult life. This project will also provide domain trained researchers with cutting edge international academic and industry expertise.Read moreRead less